Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q4 FY19
Investor Presentation
Q3 FY19
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Bearish
4
Neutral
6
Bullish
4
Bearish
26
Neutral
7
Bullish
13
Bearish
22
Neutral
1
Bullish
9

Market Cap
₹ 66 Cr
P/E
—
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
66 Cr
Low Risk
—
30.8
—
0.6
1.76
0.64
Sales CAGR
1Y
-36.67%
3Y
22.47%
5Y
28.71%
10Y
15.61%
Profit CAGR
1Y
-83.50%
3Y
-23.86%
5Y
—
10Y
-6.72%
ROE
TTM
-0.10%
3Y
0.66%
5Y
0.73%
10Y
2.65%
ROCE
TTM
0.05%
3Y
1.16%
5Y
1.30%
10Y
4.43%
Performance
UNDER PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
LOW MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 2.71 L in last 5 Years